Antibody association with HER-2/neu–targeted vaccine enhances CD8⁺ T cell responses in mice through Fc-mediated activation of DCs
J. Clin. Invest. Peter S. Kim, et al. 118:1700 doi:10.1172/JCI34333 [Go to this article.]

Table 3
Percentage proliferation of RNEU_420–429-specific CD8⁺ T cells 4 and 7 days after in vivo administration of vaccine + mAb